RE:RE:RE:RE:RE:JP Morgan healthcare conferenceNo company with a de-risked late-stage Phase 2 platform technology centered around a single novel biologic product that can be used to treat multiple cancers with unmet medical needs, and that is ready to commercialize, would be seeking to license or arranging a "financing" deal at his time in the product's life-cycle,
Such development deals are conducted outside of a Business Development centric meeting like the 'premier' JP Morgan Healthcare Conference, and without the need for the entire Executive team to be present. . JP Morgan is the largest and most important healthcare investment symosium in the world, and is a confrence where big Biopharma M&A deals are made.
ONCY has stated that they are ready to commercialize pelareorep and commercialization is done through a Big Pharma's marketing prowness and this happens when Big Pharma acquires such platform asset and brings that asset "in-house" to market and develop further.